Showing results (31-40 of 56) with videos related to
Sort By:
Pageof 6
Biotechnology Journal|April 17, 2015
Targeting mitosis-regulating genes in cisplatin-sensitive and -resistant melanoma cells: A live-cell RNAi screen displays differential nucleus-derived phenotypesHolger Erfle, K Pashayeva, N Harder, et al.Acta Radiologica (Stockholm, Sweden : 1987)|October 27, 2007
Pulmonary artery diameters measured by multidetector-row computed tomography in healthy adultsU Bozlar, F Ors, O Deniz, et al.Oncology Reports|August 19, 2000
Antitumoral action of 2-deoxy-D-glucose tetraacetate in human melanoma cellsU Reinhold, S Ugurel, W Tilgen, et al.AJNR. American Journal of Neuroradiology|May 15, 2007
Safety and feasibility of intra-arterial nicardipine for the treatment of subarachnoid hemorrhage-associated vasospasm: initial clinical experience with high-dose infusionsJ G Tejada, R A Taylor, M S Ugurel, et al.The British Journal of Radiology|June 17, 2010
Anatomical variations of hepatic arterial system, coeliac trunk and renal arteries: an analysis with multidetector CT angiographyM S Ugurel, B Battal, U Bozlar, et al.The British Journal of Dermatology|August 2, 2003
Melanoma-associated retinopathy: high frequency of subclinical findings in patients with melanomaC Pföhler, A Haus, A Palmowski, et al.Journal of the European Academy of Dermatology and Venereology : JEADV|December 2, 2021
Management of partial and non-responding cutaneous squamous cell carcinomaP Jansen, G C Lodde, K G Griewank, et al.Journal of the European Academy of Dermatology and Venereology : JEADV|March 11, 2015
Erythema nodosum-like lesions during BRAF inhibitor therapy: Report on 16 new cases and review of the literatureR Mössner, L Zimmer, C Berking, et al.Leukemia|May 3, 2002
CD4+CD7- leukemic T cells from patients with Sézary syndrome are protected from galectin-1-triggered T cell deathG Rappl, H Abken, J M Muche, et al.Der Hautarzt; Zeitschrift Fur Dermatologie, Venerologie, Und Verwandte Gebiete|June 7, 2014
[Cutaneous side effects of anti-tumor therapy with BRAF and MEK inhibitors]R Gutzmer, J C Hassel, K C Kähler, et al.Pageof 6